{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:23:14Z","timestamp":1783466594068,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Academic Research Projects of Southwest Medical University","award":["2023QN042"],"award-info":[{"award-number":["2023QN042"]}]},{"DOI":"10.13039\/501100019971","name":"Science and Technology Bureau of Luzhou","doi-asserted-by":"crossref","award":["2024JYJ064"],"award-info":[{"award-number":["2024JYJ064"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Southwest Medical University Cooperation Application Foundation","award":["2023LZXNYDJ045"],"award-info":[{"award-number":["2023LZXNYDJ045"]}]},{"name":"The Affiliated Hospital, Southwest Medical University Cooperation Application Foundation","award":["2024LCYXZX09"],"award-info":[{"award-number":["2024LCYXZX09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51083-z","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:16:25Z","timestamp":1778156185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CCT2 regulates the proliferation, apoptosis, and cell cycle arrest of multiple myeloma cells through the P53 signalling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Hongxiu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1280-9950","authenticated-orcid":false,"given":"Chunlan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"2","key":"51083_CR1","doi-asserted-by":"publisher","first-page":"13020216","DOI":"10.3390\/cancers13020216","volume":"13","author":"T Hideshima","year":"2021","unstructured":"Hideshima, T. & Anderson, K. C. Signaling Pathway Mediating Myeloma Cell Growth and Survival. Cancers (Basel). 13 (2), 13020216. https:\/\/doi.org\/10.3390\/cancers13020216 (2021).","journal-title":"Cancers (Basel)"},{"issue":"6","key":"51083_CR2","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1002\/cam4.5422","volume":"12","author":"S Li","year":"2023","unstructured":"Li, S. et al. Comparison between ixazomib+cyclophosphamide+dexamethasone regimen and ixazomib+dexamethasone regimen for elderly and frail patients having newly diagnosed multiple myeloma. Cancer Med.12 (6), 6523\u20136535. https:\/\/doi.org\/10.1002\/cam4.5422 (2023).","journal-title":"Cancer Med."},{"issue":"1\u20133","key":"51083_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/17474086.2024.2316090","volume":"17","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. The effect of immunomodulatory drugs on bone metabolism of patients with multiple myeloma. Expert Rev. Hematol.17 (1\u20133), 47\u201354. https:\/\/doi.org\/10.1080\/17474086.2024.2316090 (2024).","journal-title":"Expert Rev. Hematol."},{"key":"51083_CR4","doi-asserted-by":"publisher","unstructured":"Zhong, H. et al. (18)F\u2013FDG PET\/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple myeloma. BMC Med. Imaging23(1):87 https:\/\/doi.org\/10.1186\/s12880-023-01033-2(2023).","DOI":"10.1186\/s12880-023-01033-2(2023"},{"issue":"10","key":"51083_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3760\/cma.j.issn.0253-2727.2022.10.003","volume":"43","author":"Plasma Cell Disease Group CSoHCMA,","year":"2022","unstructured":"Plasma Cell Disease Group CSoHCMA, Chinese Myeloma Committee-Chinese Hematology A Guidelines for the diagnosis and management of first relapsed multiple myeloma in China (2022). Zhonghua Xue Ye Xue Za Zhi. 43 (10), 810\u2013817. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2022.10.003 (2022).","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"51083_CR6","doi-asserted-by":"publisher","unstructured":"Liao, K. Y. et al. The efficacy and safety of triplet regimens based on pomalidomide and dexamethasone for treatment of relapsed\/refractory multiple myeloma: a systematic review and meta-analysis. Eur. Rev. Med. Pharmacol. Sci.26(21):8087\u20138097 https:\/\/doi.org\/10.26355\/eurrev_202211_30162(2022).","DOI":"10.26355\/eurrev_202211_30162(2022"},{"key":"51083_CR7","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Decreased STING predicts adverse efficacy in bortezomib regimens and poor survival in multiple myeloma. Clin. Exp. Med.25(1):37 https:\/\/doi.org\/10.1007\/s10238-025-01561-x(2025).","DOI":"10.1007\/s10238-025-01561-x(2025"},{"key":"51083_CR8","doi-asserted-by":"publisher","unstructured":"Zhang, H. T. et al. Serum metabolomics reveals the effects of accompanying treatment on fatigue in patients with multiple myeloma. Support Care Cancer31(1):43 https:\/\/doi.org\/10.1007\/s00520-022-07526-0(2022).","DOI":"10.1007\/s00520-022-07526-0(2022"},{"key":"51083_CR9","doi-asserted-by":"publisher","unstructured":"Gestaut, D. et al. Structural visualization of the tubulin folding pathway directed by human chaperonin TRiC\/CCT. Cell.185(25):4770\u20134787 ehttps:\/\/doi.org\/10.1016\/j.cell.2022.11.014(2022).","DOI":"10.1016\/j.cell.2022.11.014(2022"},{"issue":"6","key":"51083_CR10","doi-asserted-by":"publisher","first-page":"e0264651","DOI":"10.1371\/journal.pone.0264651","volume":"17","author":"A Cox","year":"2022","unstructured":"Cox, A. et al. Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood. PLoS One. 17 (6), e0264651. https:\/\/doi.org\/10.1371\/journal.pone.0264651 (2022).","journal-title":"PLoS One"},{"key":"51083_CR11","doi-asserted-by":"publisher","unstructured":"Kelly, J. J. et al. Snapshots of actin and tubulin folding inside the TRiC chaperonin. Nat. Struct. Mol. Biol.29(5):420\u2013429 https:\/\/doi.org\/10.1038\/s41594-022-00755-1(2022).","DOI":"10.1038\/s41594-022-00755-1(2022"},{"key":"51083_CR12","doi-asserted-by":"publisher","unstructured":"Liu, C. et al. Pathway and mechanism of tubulin folding mediated by TRiC\/CCT along its ATPase cycle revealed using cryo-EM. Commun. Biol.6(1):531 https:\/\/doi.org\/10.1038\/s42003-023-04915-x(2023).","DOI":"10.1038\/s42003-023-04915-x(2023"},{"key":"51083_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.986990","author":"W Lv","year":"2022","unstructured":"Lv, W. et al. Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer. Front. Oncol.https:\/\/doi.org\/10.3389\/fonc.2022.986990 (2022). 12:986990.","journal-title":"Front. Oncol."},{"key":"51083_CR14","doi-asserted-by":"publisher","unstructured":"Showalter, A. E. et al. Investigating Chaperonin-Containing TCP-1 subunit 2 as an essential component of the chaperonin complex for tumorigenesis. Sci. Rep.10(1):798 https:\/\/doi.org\/10.1038\/s41598-020-57602-w(2020).","DOI":"10.1038\/s41598-020-57602-w(2020"},{"key":"51083_CR15","doi-asserted-by":"publisher","unstructured":"Wang, S. et al. Search for Key Genes and Functional Pathways of Ulcerative Colitis to Colon Cancer Based on Bioinformatics. Front. Oncol.12https:\/\/doi.org\/10.3389\/fonc.2022.857148 (2022).","DOI":"10.3389\/fonc.2022.857148"},{"key":"51083_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2524649","author":"M Xu","year":"2022","unstructured":"Xu, M., Gong, J. P. & Signature Immune Features, and Therapeutic Responses of a Novel Ubiquitination-Related Gene Signature in Lung Adenocarcinoma. J. Oncol.https:\/\/doi.org\/10.1155\/2022\/2524649 (2022). .2022:2524649.","journal-title":"J. Oncol."},{"issue":"3","key":"51083_CR17","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.3892\/ijo.2023.5554","volume":"63","author":"L Zheng","year":"2023","unstructured":"Zheng, L. et al. A potential tumor marker: Chaperonin containing TCP\u20131 controls the development of malignant tumors (Review). Int. J. Oncol.63 (3), 5554. https:\/\/doi.org\/10.3892\/ijo.2023.5554 (2023).","journal-title":"Int. J. Oncol."},{"issue":"2","key":"51083_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4149\/neo_2021_210818N1181","volume":"69","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. ASF1B enhances migration and invasion of lung cancers cell via regulating the P53-mediated epithelial-mesenchymal transformation (EMT) signaling pathway. Neoplasma69 (2), 361\u2013369. https:\/\/doi.org\/10.4149\/neo_2021_210818N1181 (2022).","journal-title":"Neoplasma"},{"issue":"3","key":"51083_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/cancers15030735","volume":"15","author":"Y Tozaki","year":"2023","unstructured":"Tozaki, Y. et al. The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells. Cancers (Basel). 15 (3), 735. https:\/\/doi.org\/10.3390\/cancers15030735 (2023).","journal-title":"Cancers (Basel)"},{"key":"51083_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102026","author":"M Boudny","year":"2020","unstructured":"Boudny, M. & Trbusek, M. ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias. Cancer Treat. Rev.https:\/\/doi.org\/10.1016\/j.ctrv.2020.102026 (2020). 88:102026.","journal-title":"Cancer Treat. Rev."},{"key":"51083_CR21","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.2147\/OTT.S305595","volume":"14","author":"F Cheng","year":"2021","unstructured":"Cheng, F. et al. Urolithin A Inhibits Epithelial-Mesenchymal Transition in Lung Cancer Cells via P53-Mdm2-Snail Pathway. Onco Targets Ther.14, 3199\u20133208. https:\/\/doi.org\/10.2147\/OTT.S305595 (2021).","journal-title":"Onco Targets Ther."},{"key":"51083_CR22","doi-asserted-by":"publisher","unstructured":"Mijit, M. et al. Role of p53 in the Regulation of Cellular Senescence. Biomolecules.10(3):420. (2020). https:\/\/doi.org\/10.3390\/biom10030420","DOI":"10.3390\/biom10030420"},{"key":"51083_CR23","doi-asserted-by":"publisher","unstructured":"Czeti, A. et al. Investigating the effect of immunomagnetic separation on the immunophenotype and viability of plasma cells in plasma cell disorders. Pathol. Oncol. Res.30https:\/\/doi.org\/10.3389\/pore.2024.1611882 (2024).","DOI":"10.3389\/pore.2024.1611882"},{"issue":"3","key":"51083_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.tcb.2024.06.003","volume":"35","author":"A Butera","year":"2025","unstructured":"Butera, A. (ed, I.) Deciphering the significance of p53 mutant proteins. Trends Cell. Biol.35 3 258\u2013268 https:\/\/doi.org\/10.1016\/j.tcb.2024.06.003 (2025).","journal-title":"Trends Cell. Biol."},{"key":"51083_CR25","doi-asserted-by":"crossref","unstructured":"Trinidad, A. G. et al. Interaction of p53 with the CCT complex promotes protein folding and wild-type p53 activity. Mol Cell.50(6):805-817.10.1016\/j.molcel.05.002(2013) (2013).","DOI":"10.1016\/j.molcel.2013.05.002"},{"key":"51083_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fonc.2015.00284","volume":"5","author":"R Vijayakumaran","year":"2015","unstructured":"Vijayakumaran, R. et al. Regulation of Mutant p53 Protein Expression. Front. Oncol.5, 284. https:\/\/doi.org\/10.3389\/fonc.2015.00284 (2015).","journal-title":"Front. Oncol."},{"issue":"9","key":"51083_CR27","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1182\/blood.2020008346","volume":"137","author":"J Corre","year":"2021","unstructured":"Corre, J. et al. del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma. Blood137 (9), 1192\u20131195. https:\/\/doi.org\/10.1182\/blood.2020008346 (2021).","journal-title":"Blood"},{"key":"51083_CR28","doi-asserted-by":"crossref","unstructured":"Nesnadna, R. et al. Multi-hit TP53 confers the poorest survival in multiple myeloma in the era of novel therapies. Mol Med.32(1):3.10.1186\/s10020-025-01392-2 (2025).","DOI":"10.1186\/s10020-025-01392-2"},{"key":"51083_CR29","doi-asserted-by":"crossref","unstructured":"Rajkumar, S. V. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol.99(9):1802-1824.10.1002\/ajh.27422 (2024).","DOI":"10.1002\/ajh.27422"},{"issue":"6721","key":"51083_CR30","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.adp8721","volume":"386","author":"F Kraft","year":"2024","unstructured":"Kraft, F. et al. Brain malformations and seizures by impaired chaperonin function of TRiC. Science386 (6721), 516\u2013525. https:\/\/doi.org\/10.1126\/science.adp8721 (2024).","journal-title":"Science"},{"key":"51083_CR31","doi-asserted-by":"publisher","unstructured":"Li, W., Liu, J. & Zhao, H. Prognostic Power of a Chaperonin Containing TCP-1 Subunit Genes Panel for Hepatocellular Carcinoma. Front. Genet.12 (668871). https:\/\/doi.org\/10.3389\/fgene.2021.668871 (2021).","DOI":"10.3389\/fgene.2021.668871"},{"key":"51083_CR32","doi-asserted-by":"publisher","first-page":"739660","DOI":"10.3389\/fonc.2021.739660","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Exploring the Expression and Prognostic Value of the TCP1 Ring Complex in Hepatocellular Carcinoma and Overexpressing Its Subunit 5 Promotes HCC Tumorigenesis. Front. Oncol.11, 739660. https:\/\/doi.org\/10.3389\/fonc.2021.739660 (2021).","journal-title":"Front. Oncol."},{"key":"51083_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fgene.2020.00172","volume":"11","author":"J Grantham","year":"2020","unstructured":"Grantham, J. The Molecular Chaperone CCT\/TRiC: An Essential Component of Proteostasis and a Potential Modulator of Protein Aggregation. Front. Genet.11, 172. https:\/\/doi.org\/10.3389\/fgene.2020.00172 (2020).","journal-title":"Front. Genet."},{"key":"51083_CR34","doi-asserted-by":"crossref","unstructured":"Ma, X. et al. CCT2 is an aggrephagy receptor for clearance of solid protein aggregates. Cell.185(8):1325\u20131345 e1322.10.1016\/j.cell.03.005(2022) (2022).","DOI":"10.1016\/j.cell.2022.03.005"},{"issue":"24","key":"51083_CR35","doi-asserted-by":"publisher","first-page":"13527","DOI":"10.3390\/ijms222413527","volume":"22","author":"A Kaida","year":"2021","unstructured":"Kaida, A. & Iwakuma, T. Regulation of p53 and Cancer Signaling by Heat Shock Protein 40\/J-Domain Protein Family Members. Int. J. Mol. Sci.22 (24), 13527. https:\/\/doi.org\/10.3390\/ijms222413527 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"51083_CR36","doi-asserted-by":"publisher","first-page":"12928","DOI":"10.3390\/ijms252312928","volume":"25","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Unraveling the Guardian: p53\u2019s Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies. Int. J. Mol. Sci.25 (23), 12928. https:\/\/doi.org\/10.3390\/ijms252312928 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"51083_CR37","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1002\/ptr.8157","volume":"38","author":"WW Iksen","year":"2024","unstructured":"Iksen, W. W. et al. Comprehensive review of Bcl-2 family proteins in cancer apoptosis: Therapeutic strategies and promising updates of natural bioactive compounds and small molecules. Phytother Res.38 (5), 2249\u20132275. https:\/\/doi.org\/10.1002\/ptr.8157 (2024).","journal-title":"Phytother Res."},{"key":"51083_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100712","author":"N Shahar","year":"2020","unstructured":"Shahar, N. & Larisch, S. Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance. Drug Resist. Updat. https:\/\/doi.org\/10.1016\/j.drup.2020.100712 (2020). .52:100712.","journal-title":"Drug Resist. Updat"},{"issue":"14","key":"51083_CR39","doi-asserted-by":"publisher","first-page":"e179570","DOI":"10.1172\/JCI179570","volume":"134","author":"X Tian","year":"2024","unstructured":"Tian, X. et al. Targeting apoptotic pathways for cancer therapy. J. Clin. Invest.134 (14), e179570. https:\/\/doi.org\/10.1172\/JCI179570 (2024).","journal-title":"J. Clin. Invest."},{"issue":"8","key":"51083_CR40","doi-asserted-by":"publisher","first-page":"114610","DOI":"10.1016\/j.celrep.2024.114610","volume":"43","author":"J Jansen","year":"2024","unstructured":"Jansen, J. et al. The ribosomal protein L22 binds the MDM4 pre-mRNA and promotes exon skipping to activate p53 upon nucleolar stress. Cell. Rep.43 (8), 114610. https:\/\/doi.org\/10.1016\/j.celrep.2024.114610 (2024).","journal-title":"Cell. Rep."},{"issue":"10","key":"51083_CR41","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3390\/cancers17101597","volume":"17","author":"MS Lindstrom","year":"2025","unstructured":"Lindstrom, M. S. The Central Role of Ribosomal Proteins in p53 Regulation. Cancers (Basel). 17 (10), 1597. https:\/\/doi.org\/10.3390\/cancers17101597 (2025).","journal-title":"Cancers (Basel)"},{"key":"51083_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2025.110909","author":"X Zhou","year":"2025","unstructured":"Zhou, X. et al. The study of MDM2 binding protein (MTBP) in response to apoptosis in Litopenaeus vannamei under ammonia and nitrite nitrogen stress. Fish. Shellfish Immunol. 110909. https:\/\/doi.org\/10.1016\/j.fsi.2025.110909 (2025).","journal-title":"Fish. Shellfish Immunol. 110909"},{"key":"51083_CR43","doi-asserted-by":"publisher","unstructured":"Fagundes, R. (ed, L. K.) Cyclin E\/CDK2: DNA Replication, Replication Stress and Genomic Instability. Front. Cell. Dev. Biol.9 774845 https:\/\/doi.org\/10.3389\/fcell.2021.774845 (2021).","DOI":"10.3389\/fcell.2021.774845"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51083-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51083-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51083-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:46:50Z","timestamp":1783464410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51083-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51083"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51083-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments have been reviewed and approved by the Animal Research Ethics Committee of Southwest Medical University (Approval No. 20250509-001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Informed consent forms were signed for all case reports, and permission for publication was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This study was supported by Luzhou Municipal Government\u2014Southwest Medical University Cooperation Application Foundation (grant no. 2023LZXNYDJ045), Academic Research Projects of Southwest Medical University (grant no. 2023QN042), and Science and Technology Bureau of Luzhou ((grant no.2024JYJ064).The Affiliated Hospital, Southwest Medical University Cooperation Application Foundation (grant no. 2024LCYXZX09 ).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}],"article-number":"21037"}}